TherapeuticsMD (TXMD) Depreciation & Amortization (IS) (2016 - 2025)
Historic Depreciation & Amortization (IS) for TherapeuticsMD (TXMD) over the last 13 years, with Q3 2025 value amounting to $96000.0.
- TherapeuticsMD's Depreciation & Amortization (IS) changed 0.0% to $96000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $387000.0, marking a year-over-year decrease of 6300.19%. This contributed to the annual value of $509000.0 for FY2024, which is 4479.39% down from last year.
- Per TherapeuticsMD's latest filing, its Depreciation & Amortization (IS) stood at $96000.0 for Q3 2025, which was down 0.0% from $96000.0 recorded in Q2 2025.
- Over the past 5 years, TherapeuticsMD's Depreciation & Amortization (IS) peaked at $637000.0 during Q4 2023, and registered a low of $27000.0 during Q1 2023.
- Moreover, its 3-year median value for Depreciation & Amortization (IS) was $100000.0 (2024), whereas its average is $156181.8.
- Examining YoY changes over the last 5 years, TherapeuticsMD's Depreciation & Amortization (IS) showed a top increase of 39259.26% in 2024 and a maximum decrease of 8430.14% in 2024.
- TherapeuticsMD's Depreciation & Amortization (IS) (Quarter) stood at $637000.0 in 2023, then plummeted by 84.3% to $100000.0 in 2024, then dropped by 4.0% to $96000.0 in 2025.
- Its Depreciation & Amortization (IS) stands at $96000.0 for Q3 2025, versus $96000.0 for Q2 2025 and $95000.0 for Q1 2025.